There's some good news about a coronavirus vaccine tested on older adults — a group more susceptible to severe complications from COVID-19.
Researchers at Moderna published results of a safety study Tuesday that said the vaccine provided older adults with levels of antibodies similar to younger people.
The researchers said side effects were mild and could be compared with a high-dose flu shot.
The vaccine is in Phase 3 trials — a necessary step before it can be considered for release.
